EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Time to Consider Pharmacologic Management of Unruptured Intracranial Aneurysms?

Yeon Soo Kim, Sungbin Hwang, Mi Hyeon Kim, Boseong Kwon, Yunsun Song, Deok Hee Lee

Journal of Stroke · 30.09.2025 · 27 (3) · 302-312

DOI: 10.5853/jos.2025.01662 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Stroke, erschienen am 30.09.2025. Verfasst von Yeon Soo Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing detection rate of unruptured intracranial aneurysms (UIAs) using advanced imaging underscores the need for alternative management strategies beyond surgical and endovascular interventions. Although these procedures have improved substantially, they still carry procedural risks, high costs, and psychological burdens related to continuous surveillance. This review aimed to suggest the potential role of pharmacological therapy in mitigating aneurysm progression and the risk of rupture. We first reviewed the key pathophysiological mechanisms—endothelial dysfunction, hemodynamic stress, inflammation, and thrombosis—contributing to UIA growth and instability. We then listed and examined a range of pharmacological agents, including antihypertensives, lipidlowering drugs, anti-inflammatory compounds, antioxidants, and novel candidates, summarizing both the preclinical and observational evidence supporting their use. While these findings are encouraging, current clinical data do not support broad, standardized treatment guidelines. Further prospective or randomized studies are required to clarify the safety, efficacy, and feasibility of using these agents in routine practice. By highlighting the rationale for pharmacological interventions and identifying key knowledge gaps, this review underscores the importance of an integrative management approach, encompassing medication, lifestyle modification, and vigilant monitoring, to better address patient needs and ultimately improve outcomes in UIA care.

Schlagwörter

Stichwörter der Autor:innen

Aneurysm stabilizationPharmacologic managementUnruptured intracranial aneurysm

Autor:innen und Institutionen

  • Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.
  • Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT

Zitieren

APA

Kim, Y. S., Hwang, S., Kim, M. H., Kwon, B., Song, Y., & Lee, D. H. (2025). Time to Consider Pharmacologic Management of Unruptured Intracranial Aneurysms?. Journal of Stroke, 27(3), 302-312. https://doi.org/10.5853/jos.2025.01662

Vancouver

Kim YS, Hwang S, Kim MH, Kwon B, Song Y, Lee DH. Time to Consider Pharmacologic Management of Unruptured Intracranial Aneurysms?. Journal of Stroke. 2025;27(3):302-312. doi:10.5853/jos.2025.01662

BibTeX
@article{Kim2025,
  author = {Kim, Yeon Soo and Hwang, Sungbin and Kim, Mi Hyeon and Kwon, Boseong and Song, Yunsun and Lee, Deok Hee},
  title = {Time to Consider Pharmacologic Management of Unruptured Intracranial Aneurysms?},
  journal = {Journal of Stroke},
  year = {2025},
  volume = {27},
  number = {3},
  pages = {302--312},
  doi = {10.5853/jos.2025.01662}
}
Kostenlos starten →